Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

OrbusNeich Launches US Sales with Two Balloon Catheters

publication date: Jun 6, 2017
OrbusNeich, a global company headquartered in Hong Kong, launched two balloon catheters in the US: the Sapphire™ II PRO and the Sapphire™ NC Plus. The launches are the first entries for OrbusNeich into the US market, even though it has a manufacturing plant there. OrbusNeich makes vascular interventional devices including balloon catheters and stents. The two catheters were recently granted 510k clearance by the FDA. The company has operations in Shenzhen, Florida, Hoevelaken (Netherlands), and Tokyo. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital